CRT 20/20 brings innovation to practice

The objective of the first meeting, held in Washington, DC on February 18, 1997, was to introduce a new technology to the field of interventional cardiology: vascular brachytherapy. At that time, we were combating in-stent restenosis of bare metal stents and high restenosis rates following treatment of de novo lesions with balloon angioplasty. The quest for an effective therapy to prevent or treat restenosis led to the breakthrough of vascular brachytherapy, which was emerging as an effective and safe solution to a lingering problem.
Source: Cardiovascular Revascularization Medicine - Category: Cardiology Authors: Tags: Editorial Source Type: research